Drug Detail

Information about PD-0325901

Generic Name
IND
PD-0325901
Brand Name (US)
Manufacturer
Pfizer
Drug Type
MEK inhibitor
Delivery
Oral
Approval Status
Phase 1
Indications
Overall Strategy
Oncogenic Signal Path Based
Strategy
Block KIT Signal Path
Drug Category
MEK inhibitor


Links


Trials of this drug


Trial results


Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed